beta(2)-Glycoprotein I: a novel component of innate immunity

Cetin Agar, Philip G. de Groot, Matthias Morgelin, Stephanie D. D. C. Monk, Gwendolyn van Os, Johannes H. M. Levels, Bas de Laat, Rolf T. Urbanus, Heiko Herwald, Tom van der Poll, Joost C. M. Meijers*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Sepsis is a systemic host response to invasive infection by bacteria. Despite treatment with antibiotics, current mortality rates are in the range of 20%-25%, which makes sepsis the most important cause of death in intensive care. Gram-negative bacteria are a prominent cause of sepsis. Lipopolysaccharide (LPS), one of the major constituents of the outer membrane of Gram-negative bacteria, plays a major role in activating the host's immune response by binding to monocytes and other cells. Several proteins are involved in neutralization and clearance of LPS from the bloodstream. Here, we provide evidence that ?-glycoprotein I (?GPI) is a scavenger of LPS. In vitro, ?GPI inhibited LPS-induced expression of tissue factor and IL-6 from monocytes and endothelial cells. Binding of ?GPI to LPS caused a conformational change in ?GPI that led to binding of the ?GPI-LPS complex to monocytes and ultimately clearance of this complex. Furthermore, plasma levels of ?GPI were inversely correlated with temperature rise and the response of inflammatory markers after a bolus injection of LPS in healthy individuals. Together, these observations provide evidence that ?GPI is involved in the neutralization and clearance of LPS and identify ?GPI as a component of innate immunity.
Original languageEnglish
Pages (from-to)6939-6947
Issue number25
Publication statusPublished - 23 Jun 2011

Cite this